Yttrium-90 and Rhenium-188 radiopharmaceuticals for radionuclide therapy.
"A key requirement for the effective implementation of the therapeutic approach, based on the intravenous administration of radiolabelled compounds (radionuclide therapy), is the sufficient availability of radionuclides with appropriate physical characteristics. Based on their nuclear propertie...
Saved in:
| Online Access: |
Full text (MCPHS users only) |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Vienna :
International Atomic Energy Agency,
2015
|
| Series: | IAEA radioisotopes and radiopharmaceuticals series ;
no. 5, |
| Subjects: | |
| Local Note: | ProQuest Ebook Central |
